我要投票 映泰BIOSTAR在主板行业中的票数:461
· 外 推 电 报 ·
2025-08-06 00:57:49 星期三

【映泰BIOSTAR是哪个国家的品牌?】

映泰BIOSTAR是什么牌子?「映泰BIOSTAR」是 深圳市映德电子科技有限公司 旗下著名品牌。该品牌发源于台湾,在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力映泰BIOSTAR品牌出海!将品牌入驻外推网,定制映泰BIOSTAR品牌推广信息,可以显著提高映泰BIOSTAR产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

始创于1986年台湾,世界知名的主板生产商,致力于计算机行业硬件主板系列产品的研发、生产的高科技企业。

映泰:主板大厂,与上游芯片厂商(Intel、nVIDIA、AMD等)关系密切,是nVIDIA的AIC(核心合作伙伴)。旗下主板产品拥有“十二项武器”等特色技术,比较适合家用和商用。T系列超频能力尤其出众,在DIY玩家群中拥有良好的口碑,今年又推出T-POWER系列。显卡方面具备特色超频软件,能充分发掘DIY的乐趣。不过近两年才进入DIY市场,虽然拥有“九大奇技”等特色技术,但超频能力一般,同样比较适合家用和商用。

1990年,映泰为了扩大迎合全球顾客需求的能力,是较早在中国大陆成立生产基地。

深圳市映德电子科技有限公司成立于2006年,负责在大陆研发、生产、营销和售后工作等一系列完整的映泰主板生产销售流程。

映泰早期专门生产XT架构的主板,为了保持稳定的增长,映泰尝试在产品设计和开发上不断地投入大量资金和人力,让其能够在计算机行业迅速发展的同时保持有力的竞争地位,通过给顾客提供更多综合解决方案来满足市场不断发展的需求,映泰提高了自身在产品设计和生产方面的能力,如扩展卡,多媒体和系统产品。

英文翻译:Founded in 1986 in Taiwan, the world-famous motherboard manufacturer, is committed to the computer industry hardware motherboard series product research and development, production of high-tech enterprises. Yingtai: a large main board factory, closely related to upstream chip manufacturers (Intel, NVIDIA, AMD, etc.), is the AIC (core partner) of NVIDIA. Its main board products have "Twelve weapons" and other special technologies, which are more suitable for domestic and commercial use. T series is especially outstanding in overclocking ability, and has a good reputation in DIY players. This year, T-Power series is launched again. In the aspect of video card, it has the characteristic over frequency software, which can fully explore the fun of DIY. However, it has only entered the DIY market in the past two years. Although it has "nine unique technologies" and other characteristic technologies, its overclocking ability is general, which is also suitable for home use and commercial use. In 1990, in order to expand its ability to meet the needs of global customers, Yingtai established its production base in mainland China earlier. Founded in 2006, Shenzhen Yingde Electronic Technology Co., Ltd. is responsible for a series of complete production and sales processes of Yingtai main board, including R & D, production, marketing and after-sales work in mainland China. In the early stage, Yingtai specialized in the production of XT architecture mainboard. In order to maintain stable growth, Yingtai tried to continuously invest a lot of money and manpower in product design and development, so that it could maintain a strong competitive position in the rapid development of the computer industry. By providing more comprehensive solutions to customers to meet the continuous development of the market, Yingtai improved its products Design and production capabilities such as expansion cards, multimedia and system products.

本文链接: https://www.waitui.com/brand/123203175.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

Palantir季度营收首破10亿美元大关,上调2025全年业绩指引

数据挖掘公司Palantir在人工智能热潮中再创佳绩:季度营收首次突破10亿美元大关,同比激增48%至10亿美元;调整后每股收益0.16美元,两项数据均超市场预期。公司同时将2025全年营收预期上调至41.42-41.50亿美元,显著高于此前指引。(新浪财经)

58分钟前

特朗普:将在未来24小时内大幅提高印度关税

据报道,美国总统特朗普表示,将在未来24小时内大幅提高印度关税。(界面)

58分钟前

美股大型科技股盘前多数上涨,亚马逊涨0.67%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,亚马逊涨0.67%,微软涨0.54%,英伟达涨0.37%,特斯拉涨0.23%,苹果涨0.21%,奈飞涨0.16%,谷歌涨0.14%;Meta跌0.05%。

58分钟前

热门中概股美股盘前多数上涨,哔哩哔哩涨超3%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,哔哩哔哩涨超3%,理想汽车涨超2%,蔚来、网易、富途控股、腾讯音乐涨超1%,小鹏汽车涨近1%;京东跌0.73%,百度跌0.43%。

58分钟前

石药集团:司美格鲁肽注射液上市申请获国家药监局受理

36氪获悉,石药集团发布公告,附属公司石药集团百克(山东)生物制药股份有限公司开发的司美格鲁肽注射液的上市申请已获国家药品监督管理局受理。本次申报的适应症为成人2型糖尿病患者的血糖控制。

58分钟前

本页详细列出关于映泰BIOSTAR的品牌信息,含品牌所属公司介绍,映泰BIOSTAR所处行业的品牌地位及优势。
咨询